Coronary revascularization in diabetic patients: Current state of evidence.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Experimental and Clinical Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 21523202PMCID PMC3076161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

  2009cited by this paper
• Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• A randomized trial of therapies for type 2 diabetes and coronary artery disease.

  2009cited by this paper
• The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction

  2009cited by this paper
• Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS)

  2008cited by this paper
• Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease

  2008cited by this paper
• Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

  2008cited by this paper
• Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.

  2008cited by this paper
• Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease.

  2008cited by this paper
• Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease.

  2007cited by this paper
• Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.

  2007cited by this paper
• Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

  2007cited by this paper
• Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.

  2007cited by this paper
• Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease

  2007cited by this paper
• Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease

  2007cited by this paper
• Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up.

  2007cited by this paper
• Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.

  2007cited by this paper
• Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery

  2007cited by this paper
• Diabetes and Percutaneous Interventional Therapy

  2005cited by this paper
• Diabetes and coronary revascularization.

  2005cited by this paper
• One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.

  2005cited by this paper
• Cardiac Surgery and Diabetes Mellitus

  2005cited by this paper
• Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).

  2005cited by this paper
• Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.

  2005cited by this paper
• FOCUS ISSUE: DRUG-ELUTING STENTS: TAXUS-IV Outcomes With the Polymer-Based Paclitaxel-Eluting TAXUS Stent in Patients With Diabetes Mellitus The TAXUS-IV Trial

  2005cited by this paper
• Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

  2005cited by this paper
• Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).

  2005cited by this paper
• Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

  2005cited by this paper
• A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

  2004cited by this paper
• Long-term, cause-specific mortality after myocardial infarction in diabetes.

  2004cited by this paper
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

  2004cited by this paper
• Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

  2004cited by this paper
• Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy

  2004cited by this paper
• Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000

  2004cited by this paper
• Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

  2003cited by this paper
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

  2003cited by this paper
• Valvular heart operation is an independent risk factor for acute renal failure.

  2003cited by this paper
• A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes.

  2003cited by this paper
• Aortic valve replacement in patients with impaired ventricular function.

  2003cited by this paper
• Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.

  2003cited by this paper
• Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients.

  2003cited by this paper
• Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction.

  2003cited by this paper
• Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease.

  2003cited by this paper
• Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years.

  2003cited by this paper
• Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).

  2002influential reference
• Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Insulin resistance, a new target for nitric oxide‐delivery drugs

  2002cited by this paper
• Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry.

  2002cited by this paper
• Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery.

  2002cited by this paper
• Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

  2002cited by this paper
• Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients.

  2002cited by this paper
• Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial.

  2002cited by this paper
• Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.

  2001cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001cited by this paper
• Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997: The Minnesota Heart Survey

  2001cited by this paper
• [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations].

  2000cited by this paper
• Obesity, insulin resistance and diabetes — a worldwide epidemic

  2000cited by this paper
• Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations.

  2000cited by this paper
• Management of coronary artery disease: therapeutic options in patients with diabetes.

  2000cited by this paper
• Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

  2000cited by this paper
• Clinical benefits of endoscopic vein harvesting in patients with risk factors for saphenectomy wound infections undergoing coronary artery bypass grafting.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)

  2000cited by this paper
• Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)

  2000cited by this paper
• Risk factors for early or delayed stroke after cardiac surgery.

  1999cited by this paper
• Diabetes and complications after cardiac surgery: comparison with a non-diabetic population

  1999cited by this paper
• Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients.

  1999cited by this paper
• Comparison of long-term clinical results of double versus single internal mammary artery bypass grafting.

  1999cited by this paper
• Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.

  1999cited by this paper
• Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

  1998cited by this paper
• Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.

  1998cited by this paper
• Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease.

  1998cited by this paper
• Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.

  1998cited by this paper
• Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting

  1998cited by this paper
• Exploding type II

  1998cited by this paper
• Diabetes. Exploding type II.

  1998cited by this paper
• Trends in ischemic heart disease deaths--United States, 1990-1994.

  1997cited by this paper
• From the Centers for Disease Control and Prevention. Trends in ischemic heart disease deaths--United States, 1990-1994.

  1997cited by this paper
• Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.

  1997cited by this paper
• Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)

  1997cited by this paper
• Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients.

  1997cited by this paper
• The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010

  1997cited by this paper
• Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

  1996influential reference
• Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery.

  1996cited by this paper
• Appointment of New Associate Editor for Circulation

  1996cited by this paper
• Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

  1996cited by this paper
• Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.

  1996cited by this paper
• Factors predisposing to median sternotomy complications. Deep vs superficial infection.

  1996cited by this paper
• Predictors of low cardiac output syndrome after coronary artery bypass.

  1996cited by this paper
• Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

  1996cited by this paper
• NHLI BARI clinical alert on diabetics treated with angioplasty.

  1995cited by this paper
• First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants.

  1995cited by this paper
• Prognosis of patients > or = 70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients > or = 70 years of age with Q-wave acute myocardial infarction.

  1995cited by this paper
• Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

  1995cited by this paper
• Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

  1995cited by this paper
• Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI).

  1995cited by this paper
• First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation)

  1995cited by this paper

• The relationships between biological novel biomarkers Lp‐PLA2 and CTRP‐3 and CVD in patients with type 2 diabetes mellitus

  2024cites this paper
• Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft In- hospital Outcomes in Diabetes

  2023cites this paper
• Diabetes Mellitus in Acute Coronary Syndrome

  2023cites this paper
• Is Coronary Artery Bypass Grafting (CABG) Surgery Still Preferable to Percutaneous Coronary Intervention (PCI) in View of Long-Term Outcomes among Diabetic Patients?

  2023influential citation
• Outcomes of myocardial revascularization in diabetic patients with left main coronary artery disease: A multicenter observational study from three gulf countries.

  2022cites this paper
• Effect of a gamified digital platform in increasing learning about the prevention of metabolic syndrome, obesity, and type 2 diabetes mellitus

  2022cites this paper
• Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy.

  2022cites this paper
• Melatonin attenuates restenosis after vascular injury in diabetic rats through activation of the Nrf2 signaling pathway.

  2021cites this paper
• CABG versus PCI in the Treatment of Unprotected Left Main Disease in Diabetics: A Literature Review.

  2021cites this paper
• Two-year safety and efficacy of Indigenous Abluminus Sirolimus Eluting Stent. Does it differ amongst diabetics? – Data from en-ABLe- REGISTRY

  2021cites this paper
• Does percutaneous transluminal coronary angioplasty (PTCA) have comparable long-term outcomes compared to coronary artery bypass grafting (CABG) in diabetic patients?

  2020cites this paper
• Use of phytochemicals for the treatment of insulin resistance–linked visceral and neurological disorders

  2020cites this paper
• Revascularization Strategies for Non-ST-Elevation Myocardial Infarction

  2019cites this paper
• Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003‐2004 to 2013‐2014)

  2019cites this paper
• Obstructive and nonobstructive coronary artery disease in long-lasting type 1 diabetes: a 7-year prospective cohort study.

  2019cites this paper
• Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

  2019cites this paper
• Acute kidney injury - A clinical alert for diabetic patients requiring multi-vessel revascularization.

  2019cites this paper
• Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

  2019cites this paper
• Prognostische Aussagekraft von Gamma-Glutamyltransferase bei Patienten mit Diabetes mellitus und koronarer Herzkrankheit

  2018cites this paper
• Coronary Artery Bypass Graft

  2018cites this paper
• Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats

  2018cites this paper
• Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.

  2017cites this paper
• Management of Acute Coronary Syndromes in Patients with Diabetes.

  2017cites this paper
• Intravascular Profile of Coronary Artery Disease in Diabetic Patients with Acute Coronary Syndrome: Results of the Saudi Coronary Athero-Thrombotic Disease (SAUDICAT)

  2017cites this paper
• Management standards for stable coronary artery disease in India

  2016cites this paper
• Management Protocols of stable coronary artery disease in India: Executive summary

  2016cites this paper
• The pleiotropic effects of metformin: time for prospective studies

  2015cites this paper
• Does Diabetes Have an Influence on Regional Deformation Parameters in Patients with Normal Systolic Function during Off-Pump Coronary Artery Bypass Grafting?

  2015cites this paper
• Consensus evidence-based guidelines for management of hyperglycaemia in patients undergoing coronary artery bypass grafting in patients with diabetes in India.

  2014cites this paper
• Consensus evidence-based guidelines for management of hyperglycaemia in patients undergoing coronary artery bypass grafting in patients with diabetes in India.

  2014cites this paper
• 'FREEDOM' trial: have the interventional cardiologists lost their freedom?

  2013influential citation
• Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon

  2013cites this paper
• Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis

  2011cites this paper